Highlights Klaria Pharma Holding AB

Equities

KLAR

SE0007280326

Market Closed - Nasdaq Stockholm Other stock markets 12:00:00 2024-07-10 pm EDT			5-day change	1st Jan Change
0.32 ^SEK	-8.83%		-17.10%	-30.74%

May. 16	Klaria Pharma Holding AB (publ.) Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Feb. 29	Klaria Pharma Holding AB (publ.) Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Klaria Pharma Holding AB (publ.) Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 16	CI
Klaria Pharma Holding AB (publ.) Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 29	CI
Klaria Pharma Holding AB (publ.) Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Feb. 29	CI
Klaria Pharma Engages Ernst & Young to Review, Seek Strategic Partnerships	Feb. 26	MT
Klaria Pharma Holding AB (publ.) Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 24	CI
Klaria Pharma Holding AB (publ.) Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-25	CI
Klaria Pharma Holding AB (publ.) Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-12	CI
Klaria Pharma Faces Regulatory Probe on Inside Information Disclosures Over Rights Issue	23-03-28	MT
Klaria Pharma Holding AB (publ.) Reports Earnings Results for the Fourth Quarter Ended December 31, 2022	23-02-10	CI
Klaria Pharma Holding AB (publ.) Reports Earnings Results for the Full Year Ended December 31, 2022	23-02-10	CI
Klaria Pharma Holding AB (publ.) Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-17	CI
Klaria Pharma, Pharma Mar to Collaborate on Feasibility Study	22-10-07	MT
Klaria Pharma Holding AB (publ.) Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-26	CI
Klaria Pharma Holding AB (publ.) Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-12	CI
Klaria Pharma, FluiMed Partner to Develop Sirolimus Alginate Film to Avoid Organ Transplant Rejection	22-03-30	MT
Klaria Pharmaceuticals Enters into Agreement with FluiMed GmbH to Develop Sirolimus Alginate Film for prevention of Organ Transplant Rejection	22-03-30	CI
Klaria Pharma Holding AB (publ.) Reports Earnings Results for the Fourth Quarter Ended December 31, 2021	22-02-10	CI
Klaria Pharma Holding AB (publ.) Reports Earnings Results for the Full Year Ended December 31, 2021	22-02-10	CI
Klaria Pharma AB Initiates Clinical Study with Naloxon Alginate Film	21-12-20	CI
Klaria Pharma Wins Regulatory Nod To Launch Opioid Overdose Treatment Trial In UK	21-12-02	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Klaria Pharma Holding AB

Equities

KLAR

SE0007280326

Highlights

Filters